Genetic regulation of T regulatory, CD4, and CD8 cell numbers by the arthritis severity loci Cia5a, Cia5d, and the MHC/Cia1 in the rat

Molecular Medicine

Volumn 13, Issue 5-6, 2007, Pages 277-287

  Brenner, Max ^a,b   Laragione, Teresina ^a   Yarlett, Nuriza C ^a   Gulko, Pércio S ^a,c,d  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b Hofstra North Shore LIJ School of Medicine   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; CD45RC ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ISOLATION; CELL STRAIN; CONGENIC STRAIN; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; GENE FREQUENCY; GENE LOCUS; GENETIC REGULATION; HOMEOSTASIS; IMMUNOPATHOGENESIS; LYMPHOCYTE; LYMPHOCYTE COUNT; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; RAT; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; SPLEEN LYMPHOCYTE; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD45; ARTHRITIS, RHEUMATOID; CD8-POSITIVE T-LYMPHOCYTES; CELL COUNT; CELL DEATH; CELL PROLIFERATION; CHROMOSOMES, MAMMALIAN; CYTOKINES; HISTOCOMPATIBILITY ANTIGENS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; MICROSATELLITE REPEATS; PHENOTYPE; QUANTITATIVE TRAIT LOCI; RATS; RATS, INBRED F344; T-LYMPHOCYTES, REGULATORY;

EID: 34547474592     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/2007-00003.Brenner     Document Type: Article

References (79)

1. Weinblatt ME, Keystone EC, Furst DE, Kavanaugh AF, Chartash EK, Segurado OG. (2006) Long-term efficacy and safety of adalimumab plus methotrexate in patients with rheumatoid arthritis: ARMADA 4-year extended study Ann. Rheum. Dis. 65:753-9.
2. MacGregor AJ et al. (2000) Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum. 43:30-7.
3. Cornelis F et al. (1998) New susceptibility locus for rheumatoid arthritis suggested by a genomewide linkage study Proc. Natl. Acad. Sci. U. S. A. 95:10746-50.
4. Jawaheer D et al. (2001) A genomewide screen in multiplex rheumatoid arthritis families suggests genetic overlap with other autoimmune diseases. Am. J. Hum. Genet. 68:927-36.
5. MacKay K et al. (2002) Whole-genome linkage analysis of rheumatoid arthritis susceptibility loci in 252 affected sibling pairs in the United Kingdom. Arthritis Rheum. 46:632-9.
6. Shiozawa S et al. (1998) Identification of the gene loci that predispose to rheumatoid arthritis. Int. Immunol. 10:1891-5.
7. John S et al. (2004) Whole-genome scan, in a complex disease, using 11,245 single-nucleotide polymorphisms: comparison with microsatellites. Am. J. Hum. Genet. 75:54-64.
8. Remmers EF et al. (1996) A genome scan localizes five non-MHC loci controlling collagen-induced arthritis in rats. Nat. Genet. 14:82-5.
9. Gulko PS. et al. (1998) Identification of a new non-major histocompatibility complex genetic locus on chromosome 2 that controls disease severity in collagen- induced arthritis in rats. Arthritis Rheum. 41:2122-31.
10. Meng HC et al. (2004) Identification of two novel female-specific non-major histocompatibility complex loci regulating collagen-induced arthritis severity and chronicity, and evidence of epistasis. Arthritis Rheum. 50:2695-2705.
11. Joe BEF et al. (2000) Genetic dissection of collagen-induced arthritis in Chromosome 10 quantitative trait locus speed congenic rats: evidence for more than one regulatory locus and sex influences. Immunogenetics 51:930-44.
12. Remmers EF et al. (2002) Modulation of multiple experimental arthritis models by collagen-induced arthritis quantitative trait loci isolated in congenic rat lines: different effects of non-major histocompatibility complex quantitative trait loci in males and females. Arthritis Rheum. 46:2225-34.
13. Brenner M et al. (2005) The non-major histocompatibility complex quantitative trait locus Cia10 contains a major arthritis gene and regulates dis-ease severity, pannus formation, and joint damage. Arthritis Rheum. 52:322-32.
14. Brenner M et al. (2005) The non-MHC quantitative trait locus Cia5 contains 3 major arthritis genes that differentially regulate disease severity, pannus formation, and joint damage in collagen-and pristane-induced arthritis. J. Immunol. 174:7894-903.
15. Joe B et al. (2002) Evaluation of quantitative trait loci regulating severity of mycobacterial adjuvant-induced arthritis in monocongenic and polycongenic rats: identification of a new regulatory locus on rat chromosome 10 and evidence of overlap with rheumatoid arthritis susceptibility loci. Arthritis Rheum. 46:1075-85.
16. Holmberg J, Tuncel J, Yamada H, Lu S, Olofsson P, Holmdahl R. (2006) Pristane, a non-antigenic adjuvant, induces MHC class II-restricted, arthritogenic T cells in the rat. J. Immunol. 176:1172-9.
17. Vingsbo C, Sahlstrand P, Brun JG, Jonsson R, Saxne T, Holmdahl R. (1996) Pristane-induced arthritis in rats: a new model for rheumatoid arthritis with a chronic disease course influenced by both major histocompatibility complex and non-major histocompatibility complex genes. Am. J. Pathol. 149:1675-83.
18. Klareskog L, Holmdahl R, Larsson E, Wigzell H. (1983) Role of T lymphocytes in collagen II induced arthritis in rats. Clin. Exp. Immunol. 51:117-25.
19. Yoshino S, Cleland LG. (1992) Depletion of alpha/beta T cells by a monoclonal antibody against the alpha/beta T cell receptor suppresses established adjuvant arthritis, but not established collagen-induced arthritis in rats. J. Exp. Med. 175:907-15.
20. Durie FH, Fava RA, Foy TM, Aruffo A, Ledbetter JA, Noelle RJ. (1993) Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science 261:1328-30.
21. Knoerzer DB, Karr RW, Schwartz BD, Mengle-Gaw LJ. (1995) Collagen-induced arthritis in the BB rat. Prevention of disease by treatment with CTLA-4-Ig. J. Clin. Invest. 96:987-93.
22. Kremer, J. M., R et al. (2003) Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. N. Eng.l J. Med. 349:1907-15.
23. + T lymphocytes and class II antigen- expressing cells in joints of DBA/1 mice immunized with type II collagen. Lab. Invest. 58:53-60.
24. Moder KG, Luthra HS, Griffiths M, David CS. (1993) Prevention of collagen induced arthritis in mice by deletion of T cell receptor V β 8 bearing T cells with monoclonal antibodies. Br. J. Rheumatol. 32:26-30.
25. Yoshino S, Cleland LG, Mayrhofer G. (1991) Treatment of collagen-induced arthritis in rats with a monoclonal antibody against the alpha/ beta T cell antigen receptor. Arthritis Rheum. 34:1039-47.
26. Brennan FM, Hayes AL, Ciesielski CJ, Green P, Foxwell BM, Feldmann M. (2002) Evidence that rheumatoid arthritis synovial T cells are similar to cytokine-activated T cells: involvement of phosphatidylinositol 3- kinase and nuclear factor kappaB pathways in tumor necrosis factor α production in rheumatoid arthritis. Arthritis Rheum. 46:31-41.
27. Burger D. (2000) Cell contact-mediated signaling of monocytes by stimulated T cells: a major pathway for cytokine induction. Eur. Cytokine Netw. 11:346-53.
28. Cho ML et al. (2004) Effector function of type 11 collagen-stimulated T cells from rheumatoid arthritis patients: cross-talk between T cells and synovial fibroblasts. Arthritis Rheum. 50:776-84.
29. Koenders MI et al. (2005) Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis. Arthritis Rheum. 52:3239-47.
30. Chabaud M, Garnero P, Dayer JM, Guerne PA, Fossiez F, Miossec P. (2000) Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis. Cytokine 12:1092-9.
31. Kotake S et al. (1999) IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J. Clin. Invest. 103:1345-52.
32. + cell depletion hastens the onset of severe disease in collagen-induced arthritis. Arthritis Rheum. 48:1452-60.
33. + regulatory T cells. Arthritis Rheum. 52:2212-21.
34. + cell-depleted adult mice. Rheumatology (Oxford) 44:299-308.
35. Ehrenstein MR et al. (2004) Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFα therapy. J. Exp. Med. 200:277-85.
36. Ponchel F et al. (2002) Dysregulated lymphocyte proliferation and differentiation in patients with rheumatoid arthritis. Blood 100:4550-6.
37. Koetz K, Bryl E, Spickschen K, O'Fallon WM, Goronzy JJ, Weyand CM. (2000) T cell homeostasis in patients with rheumatoid arthritis. Proc. Natl. Acad. Sci. U. S. A. 97:9203-8.
38. Xystrakis E et al. (2006) Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. J. Clin. Invest. 116:146-55.
39. Schonland SO et al. (2003) Premature telomeric loss in rheumatoid arthritis is genetically determined and involves both myeloid and lymphoid cell lineages. Proc. Natl. Acad. Sci. U. S. A. 100:13471-6.
40. Ravlic-Gulan J, Gulan G, Novak S, Duletic-Nacinovic A, Matovinovic D, Rukavina D. (2005) A comparison of lymphocyte subpopulations simultaneously on local and systemic levels in acute rheumatoid arthritis patients. Coll. Antropol. 29:661-9.
41. Cantagrel A et al. (1988) The transsynovial lymphocytic ratio. Characterization of blood and synovial fluid lymphocytes from patients with arthritic diseases. J. Rheumatol 15:899-904.
42. Damoiseaux JG et al. (1999) A dominant role for the thymus and MHC genes in determining the peripheral CD4/CD8 T cell ratio in the rat. J. Immunol. 163:2983-9.
43. + T regulatory cells. Nat. Immunol. 4:337-42.
44. + T regulatory cells. J. Exp. Med. 199:323-35.
45. Lu S, Holmdahl R. (1999) Different therapeutic and bystander effects by intranasal administration of homologous type II and type IX collagens on the collagen-induced arthritis and pristane-induced arthritis in rats. Clin. Immunol. 90:119-27.
46. Thompson SJ et al. (1993) Prevention of pristane-induced arthritis by the oral administration of type II collagen. Immunology 79:152-7.
47. + T cell subset that inhibits this autoimmune potential. J. Exp. Med. 177:627-36.
48. + and CD25-subpopulations. J. Immunol. 165:3105-10.
49. + T cells in rats. Int. Immunol. 16:365-75.
50. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155:1151-64.
51. Stephens LA, Mottet C, Mason D, Powrie F. (2001) Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur J. Immunol. 31:1247-54.
52. + T cell subset in the BB rat model of autoimmune diabetes expresses neither CD25 nor Foxp3. J. Immunol. 177:7820-32.
53. + regulatory T cells in health and disease. Clin. Exp. Pharmacol. Physiol. 33:519-24.
54. Seddon B, Mason D. (1999) Peripheral autoantigen induces regulatory T cells that prevent autoimmunity. J. Exp. Med. 189:877-82.
55. + T lymphocytes. J. Immunol. 142:748-52.
56. + cells suppress oil-induced arthritis. Clin. Exp. Immunol. 120:532-6.
57. + T cells in murine experimental allergic encephalomyelitis. Science 256:1213-5.
58. Zhang X, Jiang S, Manczak M, Sugden B, Adamus G. (2002) Phenotypes of T cells infiltrating the eyes in autoimmune anterior uveitis associated with EAE. Invest. Ophthalmol. Vis. Sci. 43:1499-508.
59. Yamaguchi YN et al. (1998) Infiltrating CD45RC-T cells are associated with immunologic unresponsiveness induced by donor class I major histocompatibility complex antigens in rats. Hepatology 28:450-8.
60. Xystrakis E et al. (2004) Identification of a novel natural regulatory CD8 T-cell subset and analysis of its mechanism of regulation. Blood 104:3294-301.
61. Vukmanovic-Stejic M, Vyas B, Gorak-Stolinska P, Noble A, Kemeny DM. (2000) Human Tc1 and Tc2/Tc0 CD8 T-cell clones display distinct cell surface and functional phenotypes. Blood 95:231-40.
62. lo T cells in experimental autoimmune uveitis (EAU). J. Neuroimmunol. 183:81-8.
63. Xystrakis E et al. (2004) Functional and genetic analysis of two CD8 T cell subsets defined by the level of CD45RC expression in the rat. J. Immunol. 173:3140-7.
64. Saoudi A, Seddon B, Fowell D, Mason D. (1996) The thymus contains a high frequency of cells that prevent autoimmune diabetes on transfer into prediabetic recipients. J. Exp. Med. 184:2393-8.
65. - thymocytes that express L-selectin protect rats from diabetes upon adoptive transfer. Eur. J. Immunol. 26:2702-8.
66. Annunziato F et al. (2002) Phenotype, localization, and mechanism of suppression of CD4(+)CD25(+) human thymocytes. J. Exp. Med. 196:379-87.
67. + T lymphocytes from MHC class II-deficient mice exhibit regulatory activity. J. Immunol. 175:246-53.
68. Gregersen PK, J. Silver J, Winchester RJ. (1987) The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 30:1205-13.
69. Stastny P. (1978) Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N. Eng.l J. Med. 298:869-71.
70. Rothenberg EV, Taghon T. (2005) Molecular genetics of T cell development. Ann. Rev. Immunol. 23:601-49.
71. Corthay A, Johansson A, Vestberg M, Holmdahl R. (1999) Collagen-induced arthritis development requires alpha/beta T cells but not gammadelta T cells: studies with T cell-deficient (TCR mutant) mice. Int. Immunol. 11:1065-73.
72. Skelsey ME, Mellon J, Niederkorn JY (2001) gama/delta T cells are needed for ocular immune privilege and corneal graft survival. J. Immunol. 166:4327-33.
73. Brenner M, Laragione T, Yarlett NC, Li W, Mello A, Gulko PS. 2006. Cia27 is a novel non-MHC arthritis severity locus on rat chromosome 10 syntenic to the rheumatoid arthritis 17q22-q25 locus. Genes Immun. 7:335-41.
74. Salmon M et al. (1997) Inhibition of T cell apoptosis in the rheumatoid synovium. J. Clin. Invest. 99:439-46.
75. Hsu HC et al. (2002) Age-related change in thymic T-cell development is associated with genetic loci on mouse chromosomes 1, 3, and 11. Mech. Ageing Dev. 123:1145-58.
76. Havelkova H, Krulova M, Kosarova M, Holan V, Hart AA, Demant P, Lipoldova M. (1996) Genetic control of T-cell proliferative response in mice linked to chromosomes 11 and 15. Immunogenetics 44:475-477.
77. Krulova MH et al. (1997) IL-2-induced proliferative response is controlled by loci Cinda1 and Cinda2 on mouse chromosomes 11 and 12: a distinct control of the response induced by different IL-2 concentrations. Genomics 42:11-15.
78. Subra JF et al. (2001) The balance between CD45RChigh and CD45RClow CD4 T cells in rats is intrinsic to bone marrow-derived cells and is genetically controlled. J. Immunol. 166:2944-52.
79. + T cells. Microbiol. Immunol. 37:623-32.